Genetic Technologies Ltd has released a press release.
Genetic Technologies 1H FY22 results
Filed with ASX ·
6ix hasn’t read this filing yet.
Genetic Technologies Limited on 6ix
In the deck
Earlier from Genetic Technologies
- Half Year Report and Accounts
- US Patent Office Grants Patent for COVID-19 Risk Test
- GeneType Multi-Test Approved for Commercial Release
- Quarterly Activities Report & Appendix 4C
- Momentum Building with Cash Receipts up 112% for Q2 FY22
Later from Genetic Technologies
- Acquisition of Global Direct to Consumer Ecommerce Business
- Transformational Pathway to US Payer System
- GeneType Risk Assessment Test Onboarding in 16 clinics
- EasyDNA Expands Indian and European Markets
- Completion of AffinityDNA Acquisition
Follow Genetic Technologies into a list and get an email when it puts out news.
Follow Genetic Technologies